期刊文献+

急性冠脉综合征治疗对策的新进展 被引量:1

下载PDF
导出
作者 吕湛
出处 《川北医学院学报》 CAS 2006年第6期499-504,共6页 Journal of North Sichuan Medical College
  • 引文网络
  • 相关文献

参考文献31

  • 1Antithrombotic Trailists' Collaboration. Collaborative recta-analysis of randomized trails of antiplatdet therapy for prevention of death,myocardial infarction, and stroke in high risk patients[J]. BMJ,2002,324(7329) :71 - 86. Erratum in: BMJ,2002,324(7330) :141
  • 2Peters RJG, Mehta SR,Fox KAA, et al. Effects of aspirin dose when used alone or combination with clopidogrol in patients with acute coronary syndromes. Observations from the clopidogrol in unstable angina to prevent recurrent events(cure) study[J]. Circulation, 2003,108 (14) : 1682 - 1686
  • 3Schunemann HJ, Munger H, Brewer S, et al. Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J]. Chest,2004,126 (3 Suppl) : 174S - 178S
  • 4Cannon CP, CAPRIE Investigators. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis ( CAPRIE trial ) [ J ]. Am J Cardiol, 2002 , 90 (7) :760 - 762
  • 5CURE study investigators. The clopidogrel in unstable angina to prevent recurrent events (CURE) trail programme: rationale, design and baseline characteristics including a metaanalysis of the effects of thyenopyridines in vascular disease[J]. Eur Heart J,2000,21(24) : 2033 -2041
  • 6Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained duel oral antiplatelet therapy following percutaneous coronary interventions(CREDO trail) [J]. JAMA, 2002, 288 (19) : 2411 -2420
  • 7Gratsianskii NA. Real Ahemative to Clopidogrel. Results of the JUMBO-TIMI26 Trial[J]. Kardiologiia ,2004, 44(12) : 77 -78
  • 8Westerhout CM, Boersma E. Risk-benefit analysis of platelet glycoprotein Ⅱb/Ⅲa inhibitors in acute coronary syndromes[J]. Expert Opin Drug Saf,2003,2 ( 1 ) :49 - 58
  • 9Boersma E, Harrington RA, Moliterno DJ et al.Platelet glycoprorein Ⅱb/Ⅲa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinicals trials [ J ]. Lancet, 2002,359(9302) :189 -98. Erratum in: Lancet,2002,359(9323) :2120
  • 10James SK, Siegbahn A, Armstrong P et al. Activation of the inflammation, coagulation, and flbrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin : a GUSTO IV substudy[J].Am Heart J,2004,147(2) :267 -74

同被引文献29

引证文献1

;
使用帮助 返回顶部